Midcareer Investigator Award in Patient-Oriented Research in Aging

以患者为导向的老龄化研究中职业生涯调查员奖

基本信息

  • 批准号:
    10444914
  • 负责人:
  • 金额:
    $ 16.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary This is an application for the renewal of a K24 mentoring award for patient-oriented research (POR) from Anne Cappola, MD, ScM, Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn). The candidate has had a strong record of mentorship, leadership, and research productivity during the initial award period. Her research program encompasses POR studies at the intersection of endocrinology and geriatrics. The scientific goals of this proposal are to investigate the age- specificity of the cardiovascular risks of mild subclinical hypothyroidism and to examine thyroid stimulating hormone (TSH) testing and levothyroxine prescribing patterns in older individuals. These studies are required to support a change in the upper limit of the TSH reference range for individuals aged 65 years and older. This change would improve the health and reduce health care costs for millions of older Americans through prevention of unnecessary prescription of thyroid hormone treatment, reduction in excessive TSH monitoring, and avoidance of iatrogenic thyrotoxicosis. The mentoring goals of this application are to support the candidate’s six current K-award mentees’ transition to R01 funded independence and to engage a new generation of Penn fellows and junior faculty to conduct POR in aging. The career development goal of this application is to support the candidate’s professional development and program building in clinical investigation. This will be achieved through focused learning about biomedical informatics, engagement in Penn’s CTSA to enhance lifespan research, and ongoing leadership to promote the visibility of aging research in the endocrine community. The institutional environment for clinical and translational science at Penn is outstanding, and the proposal integrates multiple programs from Penn’s CTSA. The Department of Medicine at Penn has made a substantial commitment, including protected time and dedicated space, toward the candidate’s sustained success as a patient-oriented researcher responsible for training a new generation of junior investigators who conduct POR in older participants. Renewal of this application will allow the candidate to cement the programmatic gains achieved during the initial award period and to assure their sustainability after the renewal has completed.
项目摘要 这是一份K24指导奖的延续申请,用于Anne的以患者为导向的研究(POR) Cappola,医学博士,ScM,宾夕法尼亚大学佩雷尔曼医学院医学教授, 宾夕法尼亚州(Penn)。候选人在指导、领导和研究方面有很好的记录 在最初的奖励期间的生产力。她的研究项目包括在 内分泌学和老年病学交叉学科。这项提案的科学目标是调查年龄- 轻度亚临床甲状腺功能减退症心血管风险的特异性,并检查甲状腺刺激 激素(TSH)测试和左旋甲状腺素处方模式在老年人。这些研究是必需的 支持65岁及以上人群TSH参考范围上限的变更。这 改变将通过以下方式改善数百万美国老年人的健康状况, 防止不必要的甲状腺激素治疗处方,减少过度TSH监测, 和避免医源性甲状腺毒症。此应用程序的指导目标是支持 候选人的六名现任K奖学员过渡到R 01资助的独立性,并聘请一个新的 宾夕法尼亚大学的研究员和初级教师的一代进行老化的POR。本职业发展目标 申请是为了支持候选人的专业发展和临床项目建设 调查这将通过重点学习生物医学信息学,参与 宾夕法尼亚大学的CTSA,以加强寿命研究,并持续领导,以促进老龄化研究的可见性 在内分泌界。宾夕法尼亚大学临床和转化科学的制度环境是 该提案整合了宾夕法尼亚大学CTSA的多个项目。医学系 宾大已经做出了实质性的承诺,包括保护时间和专用空间, 候选人的持续成功,作为一个以病人为导向的研究人员负责培训新一代的 在老年参与者中进行POR的初级研究者。更新此申请将允许候选人 巩固最初授标期间取得的方案成果,并确保其可持续性 更新完成后。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNE R CAPPOLA其他文献

ANNE R CAPPOLA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNE R CAPPOLA', 18)}}的其他基金

Levothyroxine Dosing in Older Individuals
老年人的左旋甲状腺素剂量
  • 批准号:
    10638015
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
  • 批准号:
    10026340
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
  • 批准号:
    10164851
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
  • 批准号:
    10400936
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    8510209
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    10055441
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    10615121
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
  • 批准号:
    8699642
  • 财政年份:
    2013
  • 资助金额:
    $ 16.19万
  • 项目类别:
Ghrelin and Strength Training in Frail Elderly
生长素释放肽与体弱老年人的力量训练
  • 批准号:
    8332309
  • 财政年份:
    2011
  • 资助金额:
    $ 16.19万
  • 项目类别:
Ghrelin and Strength Training in Frail Elderly
生长素释放肽与体弱老年人的力量训练
  • 批准号:
    8249657
  • 财政年份:
    2011
  • 资助金额:
    $ 16.19万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了